Market Overview:
The global creatine kinase test kit market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of heart diseases and strokes, growing awareness about early diagnosis and treatment of heart diseases, and rising demand for point-of-care testing devices. The global creatine kinase test kit market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into enzyme coupling method and colorimetry method. The enzyme coupling method segment is expected to grow at a higher CAGR than the colorimetry method segment during the forecast period from 2018 to 2030 owing to its advantages such as high accuracy and precision, short turnaround time, low cost per test strip compared with other methods available in the market such as ELISA or immunoassay techniques), etc. On the basis of application,the global creatine kinase test kitmarketis divided into laboratory use , hospital use ,and others (including sports medicine clinics). The laboratory use segment dominates this market owingtoits widespread adoption for diagnostic purposes in hospitalsand clinical laboratories across different regions worldwide .
Product Definition:
Creatine kinase is an enzyme that is produced in the muscles and heart. It helps turn creatine into phosphocreatine, which is used to create energy for muscle movement. A creatine kinase test kit can be used to measure the amount of this enzyme in the blood. This test can help detect problems with the muscles or heart, such as a heart attack or stroke.
Enzyme Coupling Method:
Enzyme Coupling is a chemical reaction between an enzyme and its substrate. The most common example of this is the catalytic hydrolysis of a peptide bond in the protease reaction. Enzymes are used for many applications such as protein sequencing, drug designing, diagnostics & medical research due to their specificity and speed.
Colorimetry Method:
The colorimetry method is used to measure the amount of creatinine in blood samples. The method uses a special reagent that changes color when it comes into contact with creatinine. This change in the appearance of the reagent provides an easy way to identify and measure small quantities of creatinine present in a sample without any complicated procedures or equipment.
This test is considered as one of the most important tests for monitoring kidney function, especially during treatment for diabetes.
Application Insights:
The others segment dominated the global market in terms of revenue in 2017. This is attributed to the growing number of individuals engaging in sports and other physical activities that require a high level of energy and stamina. Increasing demand for these tests by healthcare professionals for identifying muscle damage or injury along with its associated symptoms, such as pain and swelling, is also expected to drive segment growth over the forecast period.
Laboratory held the largest share owing to extensive use as a diagnostic tool for various disorders related to muscle function including myopathies (muscle diseases), rhabdomyolysis (breakdown of muscles fibers due to trauma or excessive exercise), acute kidney failure (AKF) caused due to poisoning with an element from within muscles called creatinine, pregnancy-related muscle problems known as pre-term labor or premature birth Myopathy are some examples where CK-MB can be used as a diagnostic tool.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers coupled with high awareness levels and healthcare expenditure levels are some factors responsible for its large share. In addition, the region is expected to maintain its dominance during the forecast period due to continuous technological advancements in creatine kinase testing techniques and an increase in their adoption by clinicians as well as laboratories.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing demand for advanced medical tests that are cost-effective and offer greater accuracy compared to traditional methods along with rising healthcare spending levels in developing economies such as China & India. Moreover, growing penetration of insurance coverage will further boost revenue generation prospects for this market during the estimated time span.
Growth Factors:
- Increasing awareness about the benefits of creatine kinase test kit among consumers.
- Growing demand for personalized health care services.
- Rising prevalence of chronic diseases and disorders that can be effectively managed with regular use of creatine kinase test kit.
Scope Of The Report
Report Attributes
Report Details
Report Title
Creatine Kinase Test Kit Market Research Report
By Type
Enzyme Coupling Method, Colorimetry Method
By Application
Laboratory, Hospital, Others
By Companies
Merck, Roche Diagnostics, Thermo Fisher Scientific, Abcam, Abbott, Alfa Scientific Designs, Hologic, Biomerica, Biosynex, IDL Biotech, Danaher, Alere, BioMérieux SA, LifeAssays
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Creatine Kinase Test Kit Market Report Segments:
The global Creatine Kinase Test Kit market is segmented on the basis of:
Types
Enzyme Coupling Method, Colorimetry Method
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratory, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Roche Diagnostics
- Thermo Fisher Scientific
- Abcam
- Abbott
- Alfa Scientific Designs
- Hologic
- Biomerica
- Biosynex
- IDL Biotech
- Danaher
- Alere
- BioMérieux SA
- LifeAssays
Highlights of The Creatine Kinase Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Enzyme Coupling Method
- Colorimetry Method
- By Application:
- Laboratory
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Creatine Kinase Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Creatine Kinase Test Kit is a home test that measures the level of creatine kinase in your blood. Creatine kinase is an enzyme that helps to break down muscle tissue. A high level of creatine kinase may indicate a problem with your muscle health.
Some of the major companies in the creatine kinase test kit market are Merck, Roche Diagnostics, Thermo Fisher Scientific, Abcam, Abbott, Alfa Scientific Designs, Hologic, Biomerica, Biosynex, IDL Biotech, Danaher, Alere, BioM©rieux SA, LifeAssays.
The creatine kinase test kit market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Creatine Kinase Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Creatine Kinase Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Creatine Kinase Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Creatine Kinase Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Creatine Kinase Test Kit Market Size & Forecast, 2018-2028
4.5.1 Creatine Kinase Test Kit Market Size and Y-o-Y Growth
4.5.2 Creatine Kinase Test Kit Market Absolute $ Opportunity
Chapter 5 Global Creatine Kinase Test Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Creatine Kinase Test Kit Market Size Forecast by Type
5.2.1 Enzyme Coupling Method
5.2.2 Colorimetry Method
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Creatine Kinase Test Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Creatine Kinase Test Kit Market Size Forecast by Applications
6.2.1 Laboratory
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Creatine Kinase Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Creatine Kinase Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Creatine Kinase Test Kit Analysis and Forecast
9.1 Introduction
9.2 North America Creatine Kinase Test Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Creatine Kinase Test Kit Market Size Forecast by Type
9.6.1 Enzyme Coupling Method
9.6.2 Colorimetry Method
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Creatine Kinase Test Kit Market Size Forecast by Applications
9.10.1 Laboratory
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Creatine Kinase Test Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Creatine Kinase Test Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Creatine Kinase Test Kit Market Size Forecast by Type
10.6.1 Enzyme Coupling Method
10.6.2 Colorimetry Method
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Creatine Kinase Test Kit Market Size Forecast by Applications
10.10.1 Laboratory
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Creatine Kinase Test Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Creatine Kinase Test Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Creatine Kinase Test Kit Market Size Forecast by Type
11.6.1 Enzyme Coupling Method
11.6.2 Colorimetry Method
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Creatine Kinase Test Kit Market Size Forecast by Applications
11.10.1 Laboratory
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Creatine Kinase Test Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Creatine Kinase Test Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Creatine Kinase Test Kit Market Size Forecast by Type
12.6.1 Enzyme Coupling Method
12.6.2 Colorimetry Method
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Creatine Kinase Test Kit Market Size Forecast by Applications
12.10.1 Laboratory
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Creatine Kinase Test Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Creatine Kinase Test Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Creatine Kinase Test Kit Market Size Forecast by Type
13.6.1 Enzyme Coupling Method
13.6.2 Colorimetry Method
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Creatine Kinase Test Kit Market Size Forecast by Applications
13.10.1 Laboratory
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Creatine Kinase Test Kit Market: Competitive Dashboard
14.2 Global Creatine Kinase Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Roche Diagnostics
14.3.3 Thermo Fisher Scientific
14.3.4 Abcam
14.3.5 Abbott
14.3.6 Alfa Scientific Designs
14.3.7 Hologic
14.3.8 Biomerica
14.3.9 Biosynex
14.3.10 IDL Biotech
14.3.11 Danaher
14.3.12 Alere
14.3.13 BioMérieux SA
14.3.14 LifeAssays
